ClinicalTrials.gg
Sign In

Cachexia clinical trials

The registry lists 331 studies for Cachexia across more than 10 countries. 75 are recruiting or about to start. 144 of them are mainly about Cachexia (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-09.

Get an email when these change. Save the Cachexia studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
171
Recruiting
56
Status unknown
36
Terminated
26
Not yet recruiting
16
Active, not recruiting
12

Phase

Phase 2
61
Phase 3
36
Phase 1
35
Phase 4
6
Early Phase 1
4

Where

United States
95
China
29
United Kingdom
23
Germany
21
Canada
17
France
15

Who runs them

International Food Policy Research Institute (7) · Pfizer (6) · University of Erlangen-Nürnberg Medical School (6) · Helsinn Therapeutics (U.S.), Inc (6) · National Taiwan University Hospital (6) · Norwegian University of Science and Technology (5) · M.D. Anderson Cancer Center (5) · Aga Khan University (5)

What is being tested here

Drugs under test in Cachexia studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Megestrol Acetate2714
Megestrol2714
Ponsegromab215
Olanzapine224
Rilogrotug113
Fecal microbiota101
Carnitine101
Visugromab111
Lactoferrin111
Muramidase111

Drug classes tested here NSAIDs 4 · Androgens 3

Coming up

7phase 3 studies under way
30studies finish main data collection within a year1 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 56 Cachexia studies recruiting now, 32 (57%) set no upper age limit and 15 (27%) stop at 75 or younger. 8 (14%) take children under 18. 3 (5%) are for women only and 0 (0%) for men only; 17 (30%) take healthy volunteers.

Recruiting studies that take each age, of 56
AgeWomenMen
100 (0%)0 (0%)
1844 (79%)41 (73%)
3046 (82%)43 (77%)
4047 (84%)44 (79%)
5046 (82%)45 (80%)
6544 (79%)43 (77%)
7544 (79%)43 (77%)
8538 (68%)37 (66%)

Across all 331 studies, recruiting or not: 31% stop at 75 or younger and 23% at 65; 22% take children; 5% are for women only and 2% for men only; 23% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Cachexia studies take

Of 21 phase 1 interventional studies under Cachexia, half reached primary completion within 11 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 111 mo8–25 · 21 studies——
Interventional, no phase19 mo12–49 · 77 studies—19 mo11–49 · 75 studies
Observational38 mo19–48 · 38 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 11, 2026.

Newly registered3

Studies

Recruiting first, then most recently updated. Showing 50 of 331. Browse all 331 → or search them.